Mohammed Y Khanji
Overview
Explore the profile of Mohammed Y Khanji including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
160
Citations
1460
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Saberwal B, Patel K, Klotz E, Herrey A, Seraphim A, Vandermolen S, et al.
Eur Heart J Imaging Methods Pract
. 2025 Mar;
3(1):qyaf019.
PMID: 40066148
Aims: Computed tomography (CT) is increasingly being recognized as a diagnostic modality across a range of cardiovascular conditions. Myocardial late enhancement imaging has shown value as an imaging biomarker for...
2.
Pham H, Ibrahim R, Abdelnabi M, Salih M, Khanji M, Chahal C, et al.
JACC Adv
. 2025 Feb;
4(3):101595.
PMID: 39908629
No abstract available.
3.
4.
Sanghvi M, Dhall E, Chahal C, OMahony C, Mohiddin S, Savvatis K, et al.
Eur Heart J Qual Care Clin Outcomes
. 2025 Jan;
PMID: 39749832
Aims: In light of recent advances in imaging techniques, molecular understanding and therapeutic options in hypertrophic cardiomyopathy (HCM), we performed a systematic review of current guidelines for the diagnosis and...
5.
Quiroz J, Cooper J, McCracken C, Khanji M, Laranjo L, Aung N, et al.
Eur Heart J Imaging Methods Pract
. 2025 Jan;
2(3):qyae139.
PMID: 39741927
Aims: The importance of early life factors in determining health in later adulthood is increasingly recognized. This study evaluated the association of adverse childhood experiences (ACEs) with cardiovascular magnetic resonance...
6.
Ricci F, Molinari L, Mansour D, Galanti K, Vagnarelli F, Renda G, et al.
Heart Rhythm
. 2024 Nov;
22(2):510-525.
PMID: 39613202
Mavacamten is a selective, allosteric, and reversible cardiac myosin inhibitor, representing the first disease-specific treatment for obstructive hypertrophic cardiomyopathy (HCM) that targets the core pathophysiological mechanism of this condition. Clinical...
7.
Dhall E, Mahmood A, Aung N, Khanji M
Future Cardiol
. 2024 Nov;
20(15-16):811-814.
PMID: 39539213
No abstract available.
8.
Pham H, Ibrahim R, Sainbayar E, Olson A, Singh A, Khanji M, et al.
J Am Heart Assoc
. 2024 Nov;
14(5):e037381.
PMID: 39526321
Background: Hyperlipidemia is a major cardiovascular disease (CVD) risk factor, but there are limited data on its mortality trends in CVD over time. We assessed annual hyperlipidemia-related CVD mortality trends...
9.
Ferreira J, Voon V, Khanji M
Eur Heart J Cardiovasc Imaging
. 2024 Oct;
26(1):177.
PMID: 39385604
No abstract available.
10.
Khanji M, Al-Azzani W, Abdalla S, Waqar S
Eur Heart J
. 2024 Sep;
45(39):4147-4149.
PMID: 39254028
No abstract available.